Abstract
Lysosomal proteases are known to enhance the spread of epithelial tumour cells, but little is known of the possible role of proteases in the growth of soft tissue sarcomas (STS). We investigated the expression of cathepsins D, B, S, H, L and procathepsin L in frozen sections of 34 STS from 34 patients by immunohistochemistry (IHC). Cathepsins D, B and H were relatively highly expressed in STS (77–91%). The expression rate of cathepsins S and L and of procathepsin L was lower (40–66%). Cathepsin S and L expression showed a moderate (P = 0.078 andP = 0.019) and procathepsin L a strong (P = 0.00001) correlation with the survival rate of STS patients. Cathepsin S expression is also correlated with the local recurrence rate (P < 0.01). Lysosomal proteases may play a role in STS progression, and cathepsin expression may also have, significance as a prognostic factor in STS.
Similar content being viewed by others
References
Aaltonen M, Lipponen P, Kosma V-M, Aaltomaa S, Syrjänen K (1995) Prognostic value of cathepsin D in female breast cancer. Anticancer Res 15:1033–1038
Buck MR, Karustis DG, Day NA, Horn KV, Sloane BF (1992) Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissue. Biochem J 282:273–278
Castiglioni T, Merino MJ, Elsner B, Lah TT, Sloane BF, Emmert-Buck MR (1994) Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol 25:857–862
Chambers AF, Colella R, Denhardt DT, Wilson SM (1992) Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic,ras-transformed NIH 3T3 cells. Mol Carcinog 5:238–245
Chang AE, Sondak VK (1995) Clinical evaluation and treatment of soft tissue tumors. In: Enzinger FM, Weiss SW (eds) Soft tissue tumors, 3rd edn. Mosby, St Louis, pp 17–38
Chapman HA, Munger JS, Shi G-P (1994) The role of thiol proteases in tissue injury and remodeling. Am J Respir Crit Care Med 150:155–159
Dickinson AT, Fox SB, Newcomb PV, Persad RA, Sibley GN, Harris AL (1995) An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. J Urol 154:237–241
Enzinger FM, Weiß SW (1995) General considerations. In: Enzinger FM, Weiss SW (eds) Soft tissue tumors, 3rd edn. Mosby, St Louis, pp 1–18
Fong Y, Coit DG, Woodruff JM, Brennan, MF (1993) Lymph node metastasis from soft tissue sarcoma in adults: analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 217:72–77
Frühlich E, Schaumburg-Lever G, Klessen C (1995) Immunocytochemical and immunoelectron microscopic demonstration of cathepsin B in human malignant melanoma. Br J Dermatol 132:867–875
Geiler T, Kriegsman J, Keyszer GM, Gay RE, Gay S (1994) A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into scid mice. Arthritis Rheum 37:1664–1671
Giuliano AE, Eilber FR (1985) The rationale for planned reoperation after unplanned total excision of soft-tissue sarcoma. J Clin Oncol 3:1344–1348
Guangliardi LE, Koppelman B, Blum JS, Marks MS, Creswell P, Brodsky FM (1990) Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343:133–139
Holm R, Tanum G (1996) Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. Virchows Arch 428:85–89
Kageshita T, Yoshii A, Kimura T, Maruo K, Ono T, Himeno M, Nishimura Y (1995) Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours. Arch Dermatol Res 287:266–272
Kirschke H, Barret AJ (1986) Chemistry of lysosomal proteases. In: Glaumann H, Ballard F (eds) Lysosomes: their role in protein breakdown. Academic Press, London, pp 193–238
Mrschke H, Wiederanders B (1994) Cathepsin S and related lysosomal endopeptidases. Methods Enzymol 244:501–510
Kirschke H, Langner J, Wiederanders B, Ansorge S (1972) Isolierung and Charakterisierung von Peptidasen aus Rattenleberlysosomen. Acta Biol Med Germ 28:305–322
Kirschke H, Wiederanders B, Brömme D, Rinne A (1989) Cathepsin S and related lysosomal endopeptidases. Biochem J 264:467–475
Kirschke H, Peinze S, Laube F, Weber E (1995) Occurrence and processing of cathepsin S in tumour cells. In: Suzuki M, Hiwasa T (eds) Proceedings of the 1994 Chiba International Symposium on Cancer. Monduzzi, Bologna, pp 45–49
Lemere CA, Munger JS, Shi G-P, Natkin L, Haass C, Chapman HA, Selkoe DIN (1995) The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. Am J Pathol 146:848–860
Makar R, Mason A, Kittelson JM, Bowden GT, Cress AE, Nagle RB (1994) Immunohistochemical analysis of cathepsin D in prostate carcinoma. Modern Pathol 7:747–751
Mikkelsen T, Yan P-S, Ho K-L, Sameni M, Sloane BF, Rosenblum ML (1995) Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 83:285–290
Potter DA, Glenn J, Kinsella T (1985) Patterns of recurrence in patients with high grade soft-tissue sarcomas. J Clin Oncol 3:353–358
Qian F, Bajkowski AS, Steiner DF, Chan SJ, Frankfater A (1989) Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissue. Cancer Res 49:4870–4875
Remmele W, Sauer-Manthey J (1993) Comparative biochemical studies on the cathepsin D content of human breast cancer. Virchows Arch [A] 422:467–473
Rempel SA, Rosenblum ML, Mikkelsen T, Yan P-S, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G, Sloane BF (1994) Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54:6027–6031
Resnick MJM, Uhlman D, Niehans GA, Gapany M, Adams G, Knapp G, Jaszcz W (1995) Cervical lymph node status and survival in laryngeal carcinoma: Prognostic factors. Ann Otol Rhinol Laryngol 104:685–694
Roche PA, Cresswell P (1990) Proteolysis of the class II-associated invariant chain generates a peptide binding in intracellular HLA-DR molecules. Proc Natl Acad Sci USA 88:3150–3154
Rozhi J, Wade RL, Horn KV Sloane BF (1989) Membrane associated cathepsin L: a role in metastasis of melanomas. Biochem Biophys Res Commun 164:556–561
Samuel SK, Hurta RA, Kondaiah P, Khalil N, Turley EA, Wright JA, Greenberg AH (1992) Autocrine induction of tumor protease production and invasion by a metallothioneinregulated TGF-beta 1 (Ser223, 225). EMBO J 11:1599–1605
Sinha AA, Gleason DF, Staley NA, Wilson MJ, Sameni M, Sloane BF (1995) Cathepsin B in angiogenesis of human prostate: An immunohistochemical and immunoelectron microscopic analysis. Anat Rec 241:353–362
Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, Liotta LA, Nicolson GL, Rao JS (1995) Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metastasis 13:49–56
Sloane BF, Rozhin J, Moin K, Ziegler G, Fong D, Muschel RJ (1992) Cystein endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Biol Chem Hoppe Seyler 373:589–594
Solovyeva NI, Balayevskaya TO, Dilakyan EA, ZakamaldinaZama TA, Pozdnev VF, Topol LZ, Kisseljov FL (1995) Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. Int J Cancer 60:495–500
Stearns NA, Dong JM, Pan JX, Brenner DA, Sahagian GG (1990) Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels. Arch Biochem Biophys 283:447–457
Sukoh N, Abe S, Nakajiama I, Ogura S, Isobe H, Inoue K, Kawakami Y (1994) Immunohistochemical distribution of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis. Virchows Arch [A] 424: 33–38
Tern B, Brisson J, Cote C, Brisson S, Potvin D, Roberge N (1993) Prognostic significance of cathepsin D in node positive breast carcinoma: an immunohistochemical study. Int J Cancer 55:429–435
Trabandt A, Müller-Ladner U, Kriegsmann J, Gay RE, Gay S (1995) Expression of proteolytic cathepsins B, D and L in periodontal gingival fibroblasts and tissue. Lab Invest 73:205–212
Tsushima H, Ueki A, Matsuoka Y, Mihara H, Hopsu-Havu VK (1991) Characterisation of a cathepsin-H like enzyme from a human melanoma cell line. Int J Cancer 48:726–732
Unnik JAM van, Coindre JM, Contesso G, Albus-Lutter CE, Schiodt T, Garcia-Miralles T (1988) Grading of soft tissue sarcomas: experience of the EORTC soft tissue sarcoma treatment. In: Ryan JR, Baker LO (eds) Kluwer, Dordrecht, pp 7–13
Veneroni S, Daidone MG, Fronzo GD, Cappelletti V, Amadori D, Riccobon A, Paradiso A, Correale M, Silvestrini R (1993) Quantitative immunohistochemical determination of cathepsin D and its relation with other variables. Breast Cancer Res Treat 26:7–13
Weber E, Günther D, Laube F, Wiederanders B, Kirschke H (1994) Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumor growth. J Cancer Res Clin Oncol 120:564–567
Wiederanders B, Kirschke H (1986) Antibodies to rat liver cathepsins. Characterization and use for the identification of enzyme precursors. Biochem Biomed Acta 45:1421–1431
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Würl, P., Taubert, H., Meye, A. et al. Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas. Virchows Archiv 430, 221–225 (1997). https://doi.org/10.1007/BF01324805
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01324805